C36H38BrFN8O4 — CID 153306580
(1R,22R,25S)-16-acetyl-N-(6-bromo-5-fluoro-4-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide (PubChem CID 153306580) has the molecular formula C36H38BrFN8O4 and a molecular weight of 745.65 g/mol. Its IUPAC name is (1R,22R,25S)-16-acetyl-N-(6-bromo-5-fluoro-4-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide.
| Compound Name | (1R,22R,25S)-16-acetyl-N-(6-bromo-5-fluoro-4-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide |
|---|---|
| PubChem CID | 153306580 |
| Molecular Formula | C36H38BrFN8O4 |
| Molecular Weight | 745.65 g/mol |
| Exact Mass | 744.22 |
| IUPAC Name | (1R,22R,25S)-16-acetyl-N-(6-bromo-5-fluoro-4-methyl-2-pyridinyl)-13-(2-methylpyrimidin-5-yl)-4,20-dioxo-3,17,18,21-tetrazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-25-carboxamide |
| SMILES | CC(=O)c1nn2c3c(cc(-c4cnc(C)nc4)cc13)CCCCCCC(=O)NC[C@@]13C[C@@H](C(=O)Nc4cc(C)c(F)c(Br)n4)N(C(=O)C2)[C@@H]1C3 |
| InChI | InChI=1S/C36H38BrFN8O4/c1-19-10-28(42-34(37)31(19)38)43-35(50)26-13-36-14-27(36)46(26)30(49)17-45-33-22(8-6-4-5-7-9-29(48)41-18-36)11-23(24-15-39-21(3)40-16-24)12-25(33)32(44-45)20(2)47/h10-12,15-16,26-27H,4-9,13-14,17-18H2,1-3H3,(H,41,48)(H,42,43,50)/t26-,27+,36-/m0/s1 |
| InChIKey | KRAULWGIWSBOCR-QYKOWSPFSA-N |
| XLogP | 5.23 |
| TPSA | 152.07 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 50 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 745.65 |
| LogP ≤ 5 | 5.23 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|